Behance
Facebook
Instagram
Linkedin
X
Vimeo
VKontakte
Youtube
Click here - to use the wp menu builder
Search
Home
Psychedelic Stock Review
2023 Watch List
2023 Watch List
2023 Watch List
2024 Watch List
2025 Watch List
Inside the Wild Ride of ATAI (ATAI) $7.22. We’re Up And...
Editor
-
July 18, 2026
Pharmather (PHRRF) Has Officially Broken Out.
Editor / Curator
-
December 26, 2023
PharmaTher (PHRRF) Breaks Above Resistance.
Editor / Curator
-
December 19, 2023
Adding Cybin (CYBN) $0.46 to 2024 Top Psychedelic Stocks Watch List.
Editor / Curator
-
September 18, 2023
Psycheceutical’s (BWVI) Delivery Tech is Grabbing Attention. Will Pharma Listen?
Editor / Curator
-
September 8, 2023
COMPASS Pathways (CMPS) Announces Up to $285 Million Private Placement
Editor / Curator
-
August 16, 2023
Psycheceutical’s (BWVI) NeuroDirect™ Ketamine can Help Alleviate Headaches and Migraines Within...
Editor / Curator
-
June 16, 2023
Psycheceutical Bioscience (BWVI) Secures Funding for Clinical Trials
Editor / Curator
-
June 13, 2023
Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical...
Editor / Curator
-
May 22, 2023
Video: New Topical Drug Delivery System, NeuroDirect™
Editor / Curator
-
May 18, 2023
Topical PTSD Drug Poised for Human Trials.
Editor / Curator
-
May 15, 2023
Adding Psycheceutical Bioscience (BWVI) $0.14 to Watch List. Ketamine.
Editor / Curator
-
May 12, 2023
The Ketamine Endgame. Silo Pharmaceutical (SILO).
Editor / Curator
-
April 24, 2023
1
2
Page 1 of 2
